Healthcare Global Enterprises Limited has informed the Exchange regarding Appointment and re-designation of Anjali Ajaikumar as Non- Executive Director of the company w.e.f. May 30, 2025.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises (HCG) has informed the stock exchange about the re-designation of Anjali Ajaikumar as a Non-Executive Director of the company, effective May 30, 2025. The word 're-designation' indicates she was already serving on the board in another capacity (likely Executive Director) and is now being moved to a non-executive role. No other directors or key managerial personnel have been mentioned in this filing. The company has not disclosed further details such as tenure, committee assignments, or reasons for the change in this announcement. HCG is a leading cancer care hospital chain in India, listed on NSE and BSE.
Re-designation to a non-executive role is typically a routine governance change and may not have a material impact on stock price. Shareholders should monitor for any related disclosures about her prior role, compensation changes, or succession planning at the board level.